Orchard Therapeutics Plc ADR (ORTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 4,368 | 5,524 | 483 | 1,192 | 0 |
| Cost of Goods | 1,122 | 1,571 | N/A | 226 | N/A |
| Gross Profit | 3,246 | 3,953 | 483 | 966 | N/A |
| Operating Expenses | 35,817 | 42,104 | 36,898 | 34,111 | 36,013 |
| Operating Income | -32,449 | -37,580 | -36,415 | -32,919 | -36,013 |
| Interest Expense | 672 | 675 | 683 | 683 | 593 |
| Other Income | -18,014 | -5,983 | 874 | -3,976 | 747 |
| Pre-tax Income | -51,135 | -44,238 | -36,224 | -37,578 | -35,859 |
| Income Tax | -219 | 58 | 124 | -1,133 | 750 |
| Net Income Continuous | -50,916 | -44,296 | -36,348 | -36,445 | -36,609 |
| Net Income | $-50,916 | $-44,296 | $-36,348 | $-36,445 | $-36,609 |
| EPS Basic Total Ops | -3.98 | -3.50 | 7.73 | -2.90 | -2.90 |
| EPS Basic Continuous Ops | -3.98 | -3.47 | 7.67 | -2.86 | -2.91 |
| EPS Diluted Total Ops | -3.98 | -3.50 | 7.73 | -2.90 | -2.90 |
| EPS Diluted Continuous Ops | -3.98 | -3.47 | 7.67 | -2.86 | -2.91 |
| EPS Diluted Before Non-Recurring Items | -4.00 | -3.50 | -2.90 | N/A | N/A |
| EBITDA(a) | $-31,792 | $-36,958 | $-35,526 | $-31,954 | $-35,455 |